PRIVIA HEALTH GROUP INC (PRVA) — insider trading
Health Care · NASDAQ
PRIVIA HEALTH GROUP INC (PRVA) has 58 reported SEC Form 4 insider transactions in our data, including 18 open-market sales among the most recent 58 (latest 2026-09-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Ernest Opella Finley | Director | Grant / award / vesting | 6,350 | — | $0 | Form 4 |
| 2026-07-09 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 21,275 | $27.67 | $588.7K | Form 4 |
| 2026-07-07 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 600 | $27.57 | $16.5K | Form 4 |
| 2026-07-06 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 53,722 | — | $0 | Form 4 |
| 2026-07-06 | Morris Matthew Shawn | Director | Open-market sale | 53,722 | $27.24 | $1.46M | Form 4 |
| 2026-07-06 | Morris Matthew Shawn | Director | Option exercise / conversion | 53,722 | $2.00 | $107.4K | Form 4 |
| 2026-07-02 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 24,734 | $27.50 | $680.2K | Form 4 |
| 2026-07-02 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 59,037 | — | $0 | Form 4 |
| 2026-07-02 | Morris Matthew Shawn | Director | Open-market sale | 59,037 | $27.33 | $1.61M | Form 4 |
| 2026-07-02 | Morris Matthew Shawn | Director | Option exercise / conversion | 59,037 | $2.00 | $118.1K | Form 4 |
| 2026-07-01 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 82,675 | — | $0 | Form 4 |
| 2026-07-01 | Morris Matthew Shawn | Director | Open-market sale | 37,041 | $26.93 | $997.5K | Form 4 |
| 2026-07-01 | Morris Matthew Shawn | Director | Open-market sale | 45,634 | $26.52 | $1.21M | Form 4 |
| 2026-07-01 | Morris Matthew Shawn | Director | Option exercise / conversion | 82,675 | $2.00 | $165.3K | Form 4 |
| 2026-06-30 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 52,823 | — | $0 | Form 4 |
| 2026-06-30 | Morris Matthew Shawn | Director | Open-market sale | 52,823 | $25.72 | $1.36M | Form 4 |
| 2026-06-30 | Morris Matthew Shawn | Director | Option exercise / conversion | 52,823 | $2.00 | $105.6K | Form 4 |
| 2026-06-29 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 63,212 | — | $0 | Form 4 |
| 2026-06-29 | Morris Matthew Shawn | Director | Open-market sale | 63,212 | $25.33 | $1.60M | Form 4 |
| 2026-06-29 | Morris Matthew Shawn | Director | Option exercise / conversion | 63,212 | $2.00 | $126.4K | Form 4 |
| 2026-06-26 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 8,897 | — | $0 | Form 4 |
| 2026-06-26 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 1,336 | — | $0 | Form 4 |
| 2026-06-26 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 1,001 | — | $0 | Form 4 |
| 2026-06-26 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 5,962 | — | $0 | Form 4 |
| 2026-06-26 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 17,196 | $25.18 | $433.0K | Form 4 |
| 2026-06-26 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion | 17,196 | $2.00 | $34.4K | Form 4 |
| 2026-06-26 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 88,110 | — | $0 | Form 4 |
| 2026-06-26 | Morris Matthew Shawn | Director | Open-market sale | 88,110 | $25.33 | $2.23M | Form 4 |
| 2026-06-26 | Morris Matthew Shawn | Director | Option exercise / conversion | 88,110 | $2.00 | $176.2K | Form 4 |
| 2026-05-20 | KING DAVID P | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | Ryu Jaewon | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | Morris Matthew Shawn | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | McCarthy Thomas A | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | Kimmet Pamela O | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | COCOZZA NANCY G | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | BERBERIAN LANCE | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-20 | SOISTMAN FRANCIS S JR | Director | Grant / award / vesting | 8,463 | — | $0 | Form 4 |
| 2026-05-12 | Mehrotra Parth | Director, Officer (Chief Executive Officer) | Open-market sale | 15,647 | $22.64 | $354.2K | Form 4 |
| 2026-05-11 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 3,385 | $22.60 | $76.5K | Form 4 |
| 2026-05-11 | Mehrotra Parth | Director, Officer (Chief Executive Officer) | Open-market sale | 105,439 | $22.55 | $2.38M | Form 4 |
| 2026-05-04 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 1,017 | — | $0 | Form 4 |
| 2026-05-04 | Morris Matthew Shawn | Director | Open-market sale | 1,017 | $24.96 | $25.4K | Form 4 |
| 2026-05-04 | Morris Matthew Shawn | Director | Option exercise / conversion | 1,017 | $2.00 | $2.0K | Form 4 |
| 2026-05-04 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 360 | — | $0 | Form 4 |
| 2026-05-04 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 592 | — | $0 | Form 4 |
| 2026-05-04 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 52 | — | $0 | Form 4 |
| 2026-05-04 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 202 | — | $0 | Form 4 |
| 2026-05-04 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 1,206 | $25.00 | $30.1K | Form 4 |
| 2026-05-04 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion | 1,206 | $2.00 | $2.4K | Form 4 |
| 2026-05-01 | Morris Matthew Shawn | Director | Option exercise / conversion (derivative) | 17,096 | — | $0 | Form 4 |
| 2026-05-01 | Morris Matthew Shawn | Director | Open-market sale | 17,096 | $24.99 | $427.2K | Form 4 |
| 2026-05-01 | Morris Matthew Shawn | Director | Option exercise / conversion | 17,096 | $2.00 | $34.2K | Form 4 |
| 2026-05-01 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 2,331 | — | $0 | Form 4 |
| 2026-05-01 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 3,010 | — | $0 | Form 4 |
| 2026-05-01 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 541 | — | $0 | Form 4 |
| 2026-05-01 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 1,297 | — | $0 | Form 4 |
| 2026-05-01 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Open-market sale | 7,179 | $25.03 | $179.7K | Form 4 |
| 2026-05-01 | Mountcastle David | Officer (EVP & Chief Financial Officer) | Option exercise / conversion | 7,179 | $2.00 | $14.4K | Form 4 |
Ask the chat about PRVA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PRIVIA HEALTH GROUP INC (PRVA).
Last updated 2026-09-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.